__NUXT_JSONP__("/drugs/Apomab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1108170-71-3",chebiId:b,chemicalFormula:b,definition:"A fully human monoclonal antibody directed against human death receptor 5 (DR5; TRAIL-R2; TNFRSF10B) with potential pro-apoptotic and antineoplastic activities. Mimicking the natural ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand), apomab binds to DR5, which may directly activate the extrinsic apoptosis pathway and indirectly induce the intrinsic apoptosis pathway in tumor cells. DR5 is a cell surface receptor of the TNF-receptor superfamily and is expressed in a broad range of cancers.",fdaUniiCode:"703KLX5LXZ",identifier:"C71693",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C20401"],synonyms:["APOMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FApomab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Apomab","","2021-10-30T13:43:44.533Z")));